v3.26.1
GOODWILL AND INTANGIBLE ASSETS (Details Narrative) - USD ($)
Nov. 11, 2024
May 13, 2024
Nov. 12, 2024
Orocidin A/S [Member]      
Restructuring Cost and Reserve [Line Items]      
Common Stock issued in Bio-Convert business combination, net, shares 200,000 3,800,000  
Voting interest percentage 5.34% 95.00% 5.00%
Share price per share $ 3.25 $ 5.00  
Acquired intangible assets   $ 15,680,760  
Common shares acquired 29,663    
Fair value of consideration transferred $ 650,000    
Bio-Convert A/S [Member]      
Restructuring Cost and Reserve [Line Items]      
Common Stock issued in Bio-Convert business combination, net, shares 12,000,000    
Voting interest percentage 100.00%    
Share price per share $ 3.25    
Acquired intangible assets $ 26,675,670    
Fair value of consideration transferred $ 39,000,000